» Authors » Olof Breuer

Olof Breuer

Explore the profile of Olof Breuer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Breuer O, Brodin O, Razaghi A, Brodin D, Gammelgaard B, Bjornstedt M
Biomedicines . 2023 Feb; 11(2). PMID: 36830832
Cancer is one of the main causes of human death globally and novel chemotherapeutics are desperately required. As a simple selenium oxide, selenite is a very promising chemotherapeutic because of...
2.
Millischer V, Matheson G, Bergen S, Coombes B, Ponzer K, Wikstrom F, et al.
Lancet Psychiatry . 2022 May; 9(6):447-457. PMID: 35569502
Background: Lithium is the most effective treatment for bipolar disorder, resulting in strong suicide prevention effects. The therapeutic range of lithium, however, is narrow and treatment initiation requires individual titration...
3.
Kurland S, Lowdin E, Furebring M, Shams A, Chryssanthou E, Lagerback P, et al.
Mycoses . 2021 Oct; 65(1):79-87. PMID: 34709674
Background: Recent studies have shown low caspofungin concentrations in critically ill patients. In some patients, the therapeutic target, area under the total plasma concentration curve in relation to the minimal...
4.
Bonde Y, Breuer O, Lutjohann D, Sjoberg S, Angelin B, Rudling M
J Lipid Res . 2014 Aug; 55(11):2408-15. PMID: 25172631
Reduced plasma LDL-cholesterol is a hallmark of hyperthyroidism and is caused by transcriptional stimulation of LDL receptors in the liver. Here, we investigated whether thyroid hormone (TH) actions involve other...
5.
Marinova M, Lutjohann D, Breuer O, Kolsch H, Westhofen P, Watzka M, et al.
Eur J Clin Pharmacol . 2012 Aug; 69(3):467-75. PMID: 22864379
Objective: The pharmacokinetics of phylloquinone (vitamin K1) were evaluated in healthy human adult volunteers (15 male and 15 female) following oral and intravenous administration of a mixed micelles formulation (Konakion...
6.
Jokinen M, Neuvonen P, Lindgren L, Hockerstedt K, Sjovall J, Breuer O, et al.
Anesthesiology . 2007 Jan; 106(1):43-55. PMID: 17197844
Background: Ropivacaine is mainly eliminated by hepatic metabolism. The authors studied the effect of chronic end-stage liver disease on the pharmacokinetics of ropivacaine. Methods: Thirteen patients with chronic end-stage liver...